The article by Joe Shawrtz highlights the recent EU ban on trimethylbenzoyl diphenylphosphine oxide (TPO), a chemical used in gel nail polish. The ban stems from animal studies that […]
A new version of the Third Party Authorization form for DIN submissions was released on September 10th. There are new details at the end of the form (Section C) […]
The Marketed Health Products Directorate (MHPD) released two documents for consultation, building on the previous versions. GUI-0102 Good pharmacovigilance practices (GVP) guidelines and GUI-0063 Risk classification guide for […]
The Government of Canada has launched a second phase of public consultations on the Canada–United States–Mexico Agreement (CUSMA), inviting Canadians to provide their views and experiences on the agreement. […]
PRODUCT LICENSING: The NNHPD has returned to meeting its performance standards for new and post-licensing Class I and II applications. There are approximately 4150 files in Class […]
Please find below IFRA Information Letter 1214, which provides an update on the regulatory status of geraniol. IFRA and BASF SE are working together to ensure the continued use […]
The Therapeutic Goods Administration (TGA) is responding to a report from CHOICE that found several sunscreens did not meet their advertised SPF. The TGA, which regulates sunscreens as therapeutic […]
On July 9, 2025, the Government of Canada launched a Red Tape Review across the federal regulatory system. Today, those reports were tabled. Health Canada’s and Environment and Climate […]
The Good Manufacturing Practices Guide for Natural Health Products (GUI-0158) version 4 has just been released and posted on Heath Canada’s website under the Site Licensing Bulletin page (SL […]
Following a July 2023 Notice of Intent, Health Canada published an Information Bulletin to inform stakeholders of a planned consultation approach regarding potential new health and safety requirements for […]
